OCULAR THERAPY USING ALPHA-2 ADRENERGIC RECEPTOR ANTERIOR COMPOUNDS HAVING ENHANCED CLEARANCE RATES
    51.
    发明申请
    OCULAR THERAPY USING ALPHA-2 ADRENERGIC RECEPTOR ANTERIOR COMPOUNDS HAVING ENHANCED CLEARANCE RATES 审中-公开
    使用具有增强清除率的ALPHA-2 ADRENERGIC受体前体化合物进行的OCALAR治疗

    公开(公告)号:US20080112922A1

    公开(公告)日:2008-05-15

    申请号:US11949750

    申请日:2007-12-03

    IPC分类号: A61K31/765

    摘要: Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component which includes an alpha 2 adrenergic receptor agonist that is cleared from the anterior segment of an individual's eye to which the material is administered. The alpha 2 adrenergic receptor agonist may have a vitreal half-life greater than about three hours. The present materials are effective in treating an ocular condition(s) that affect the anterior segment of an eye, or the anterior and posterior segment of the eye. The materials are suitable for intravitreal or periocular administration and can provide prolonged drug delivery and therapeutic benefits to patients to which the materials have been administered. The alpha 2 adrenergic receptor agonists can be provided in liquid-containing formulations and/or bioerodible and/or non-bioerodible polymeric implants and microparticles. Methods of making and using the present materials are also described.

    摘要翻译: 眼科治疗材料,例如含液组合物和聚合物药物递送系统,包括治疗成分,其包括α2肾上腺素能受体激动剂,其从施用该物质的个体眼睛的前段清除。 α2肾上腺素能受体激动剂可具有大于约3小时的玻璃体半衰期。 本发明的材料可有效治疗影响眼前段或眼部前段和后段的眼睛状况。 这些材料适用于玻璃体内或眼周内给药,并且可以为已经施用材料的患者提供延长的药物递送和治疗益处。 α2肾上腺素能受体激动剂可以在含液制剂和/或生物可侵蚀和/或非生物可侵蚀的聚合物植入物和微粒中提供。 还描述了制备和使用本发明材料的方法。

    Layered and vectored graphical user interface to a knowledge and relationship rich data source
    52.
    发明授权
    Layered and vectored graphical user interface to a knowledge and relationship rich data source 有权
    分层和向量的图形用户界面,使知识和关系丰富的数据源

    公开(公告)号:US07292243B1

    公开(公告)日:2007-11-06

    申请号:US10611822

    申请日:2003-06-30

    申请人: James Burke

    发明人: James Burke

    IPC分类号: G06T11/20 G06F3/048

    CPC分类号: G09B5/00

    摘要: A graphical user interface provides a series of nested spherical surfaces representing a surface and/or human development at differing times in history and prehistory. An embodiment of the present invention, a knowledge web (K-Web), comprises a new, “multiple-intelligences” learning tool aimed at encouraging depth of thinking and understanding in numerous content areas. The K-Web optionally does this by presenting content in a dynamic, webbed structure that is readily accessible in many different ways to many different intelligences and cognitive styles.

    摘要翻译: 图形用户界面提供了一系列在历史和史前史的不同时间表示表面和/或人类发展的嵌套球形表面。 本发明的一个实施例,知识网络(K-Web)包括一种新的“多智能”学习工具,旨在鼓励在许多内容领域的深度思考和理解。 K-Web可以通过在动态的Webbed结构中呈现内容,可以以许多不同的方式容易地访问许多不同的智能和认知风格。

    Cathode head having filament protection features
    53.
    发明申请
    Cathode head having filament protection features 失效
    阴极头具有灯丝保护功能

    公开(公告)号:US20070183576A1

    公开(公告)日:2007-08-09

    申请号:US11343599

    申请日:2006-01-31

    IPC分类号: H01J35/06

    摘要: A cathode assembly including certain features designed to protect the integrity of a filament contained therein is disclosed. In particular, the cathode assembly is configured to prevent damage to the filament should it inadvertently contact another portion of the cathode assembly. In an example embodiment, an x-ray tube incorporating features of the present invention is disclosed. The x-ray tube includes an evacuated enclosure containing a cathode assembly and an anode. The cathode assembly includes a head portion having a head surface. A slot is defined on the head surface and an electron-emitting filament is included in the slot. A protective surface is defined on the head surface proximate to a central portion of the filament. The protective surface in one embodiment is composed of tungsten and is configure to prevent fusing of the filament to the protective surface should the filament inadvertently contact the protective surface.

    摘要翻译: 公开了一种阴极组件,其包括设计成保护其中所包含的细丝的完整性的某些特征。 特别地,阴极组件被构造成如果它不经意地接触阴极组件的另一部分,则防止对细丝的损坏。 在示例性实施例中,公开了包含本发明的特征的X射线管。 x射线管包括一个包含阴极组件和一个阳极的真空外壳。 阴极组件包括具有头表面的头部部分。 在头表面上限定狭缝,并且在槽中包括电子发射丝。 保护表面限定在靠近灯丝中心部分的头表面上。 一个实施例中的保护表面由钨组成,并且被配置为当灯丝不经意地接触保护表面时防止灯丝熔合到保护表面。

    ANTI-EXCITITOXIC SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS
    54.
    发明申请
    ANTI-EXCITITOXIC SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS 审中-公开
    抗真菌持续释放内镜植入物及相关方法

    公开(公告)号:US20070141117A1

    公开(公告)日:2007-06-21

    申请号:US11680613

    申请日:2007-02-28

    IPC分类号: A61K31/13 A61F2/02

    CPC分类号: A61K9/0051

    摘要: Biocompatible intraocular implants include an anti-excitotoxic agent and a biodegradable polymer that is effective to facilitate release of the anti-excitotoxic agent into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions, such as retinal damage, including glaucoma and proliferative vitreoretinopathy.

    摘要翻译: 生物相容性眼内植入物包括抗兴奋性毒性剂和可生物降解的聚合物,其有效促进抗兴奋性毒性剂长时间释放到眼睛中。 植入物的治疗剂可以与可生物降解的聚合物基质相关,例如基本上不含聚乙烯醇的基质。 植入物可以放置在眼睛中以治疗或减少一种或多种眼部病症的发生,例如视网膜损伤,包括青光眼和增生性玻璃体视网膜病变。

    Phototreatment device for use with coolants and topical substances
    55.
    发明申请
    Phototreatment device for use with coolants and topical substances 有权
    用于冷却剂和局部物质的光处理装置

    公开(公告)号:US20070078501A1

    公开(公告)日:2007-04-05

    申请号:US11607551

    申请日:2006-12-01

    IPC分类号: A61N5/06

    摘要: Methods and systems are disclosed for phototreatment in which replaceable containers comprising one or more adjuvant (consumable or re-useable) substances are employed. The adjuvant substance can be, for example, a topical substance or a coolant. Systems are disclosed for using a topical substance to detect contact of a phototreatment device with a tissue, detect speed of a phototreatment device over the tissue, detect regions of tissue that have been treated by a phototreatment device and/or to provide other benefits to the tissue such as improved skin tone and texture, tanning, etc. Safety systems are also disclosed that ensure that a proper consumable substance and/or container is connected to a phototreatment device and/or directed to a proper target. Additionally, cooling systems and methods that utilize phase change materials for extracting heat from a light generating device are disclosed.

    摘要翻译: 公开了用于光处理的方法和系统,其中使用包含一种或多种辅助剂(可消耗或可重复使用的)物质的可替换容器。 佐剂物质可以是例如局部物质或冷却剂。 公开了用于使用局部物质检测光处理装置与组织的接触的系统,检测组织上的光处理装置的速度,检测已由光处理装置处理的组织的区域和/或为 组织如改善的肤色和纹理,晒黑等。还公开了确保适当的消耗性物质和/或容器连接到光处理装置和/或定向到适当目标的安全系统。 此外,公开了利用相变材料从发光装置提取热量的冷却系统和方法。

    Modulators of the P2Y10 receptor useful in altering T lymphocyte function
    56.
    发明申请
    Modulators of the P2Y10 receptor useful in altering T lymphocyte function 审中-公开
    P2Y10受体的调节剂可用于改变T淋巴细胞功能

    公开(公告)号:US20060257404A1

    公开(公告)日:2006-11-16

    申请号:US11489829

    申请日:2006-07-20

    CPC分类号: G01N33/505

    摘要: The present invention relates to modulators of P2Y10. Various modulators are disclosed, including an antibody that binds specifically to P2Y10. The present invention also relates to methods of activating resting T lymphocytes and inhibiting the proliferation of activated T lymphocytes. Methods of upregulating trascription of P2Y10 mRNA in a resting T lymphocyte, methods of inducing expression of P2Y10 on the surface of a resting T lymphocyte and methods of activating a T lymphocyte are disclosed. Also disclosed are pharmaceuticals and methods of treating an immune disease.

    摘要翻译: 本发明涉及P2Y10的调节剂。 公开了各种调节剂,包括特异性结合P2Y10的抗体。 本发明还涉及激活静息T淋巴细胞并抑制活化的T淋巴细胞增殖的方法。 公开了在静息T淋巴细胞中上调P2Y10 mRNA的方法,在静息T淋巴细胞表面诱导P2Y10表达的方法和激活T淋巴细胞的方法。 还公开了治疗免疫疾病的药物和方法。

    Valve having axial and radial passages

    公开(公告)号:US20060086922A1

    公开(公告)日:2006-04-27

    申请号:US10970374

    申请日:2004-10-21

    IPC分类号: F16K51/00

    CPC分类号: F16K1/04 B01D35/153 B01D35/16

    摘要: A valve includes a valve body (100) disposable within a chamber (103) of a housing (101) and capable of being fluidly sealed with respect to the housing (101) when the valve is closed. At least one radial passage (117) is disposed in the valve body (100). At least one axial passage (119) is disposed in the valve body (100) in fluid communication with the at least one radial passage (117). When the valve at least partially opens, a fluid path opens between the valve body (100) and the housing (101), which fluid path (301) in is fluid communication with the at least one radial passage (117), and fluid from within the housing (101) is capable of passing out of the at least one axial passage (119).

    Intravitreal implants in conjuction with photodynamic therapy to improve vision
    58.
    发明申请
    Intravitreal implants in conjuction with photodynamic therapy to improve vision 审中-公开
    玻璃体内植入物结合光动力疗法改善视力

    公开(公告)号:US20050244500A1

    公开(公告)日:2005-11-03

    申请号:US11112523

    申请日:2005-04-22

    CPC分类号: A61K9/0051 A61K9/0009

    摘要: A method for treating a posterior ocular condition so as to improve vision is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory component and a bioerodible polymeric component, introducing a photoactive agent into the eye, and irradiating the eye with electromagnetic radiation, for example light energy, in order to activate the photoactive agent in the eye and treat the posterior ocular condition, thereby improving a patient's vision.

    摘要翻译: 提供了一种治疗眼后状况以改善视力的方法。 该方法包括以下步骤:将包含抗炎成分和生物可腐蚀的聚合物组分的生物可蚀解植入物引入眼睛中,将光活性剂引入眼中,以及用电磁辐射(例如光能)照射眼睛,以便 激活眼睛中的光活性剂并治疗后眼睛状况,从而改善患者的视力。

    Dispersion correction fiber, transmission system and method of operating same
    59.
    发明申请
    Dispersion correction fiber, transmission system and method of operating same 审中-公开
    色散校正光纤,传输系统及其操作方法

    公开(公告)号:US20050185905A1

    公开(公告)日:2005-08-25

    申请号:US11057313

    申请日:2005-02-11

    摘要: A dispersion correction optical fiber includes a segmented core having a central core segment, a moat segment and, preferably, a ring segment. The refractive index profile is selected to provide a total dispersion minimum which is located within an operating wavelength band of the fiber. Most preferably, the dispersion value at the minimum is more negative than −400 ps/nm/km and greater than −1200 ps/nm/km at 1550 nm. Optical transmission systems including the present invention dispersion correction optical fiber optically coupled to various transmission fibers and dispersion compensating fibers are also disclosed, as is a method of operating the dispersion correction fiber wherein the minimum is located within the desired operating wavelength band.

    摘要翻译: 色散校正光纤包括具有中心核心段,护环段和优选环形段的分段核心。 选择折射率分布以提供位于光纤的工作波长带内的总色散最小值。 最优选地,在1550nm处,最小的色散值比-400ps / nm / km更大,大于-1200ps / nm / km。 还公开了包括光学耦合到各种传输光纤和色散补偿光纤的本发明的色散校正光纤的光传输系统,以及操作色散校正光纤的方法,其中最小值位于期望的工作波长带内。